GT
BLFS icon

Glenmede Trust’s BioLife Solutions BLFS Stock Holding History

Glenmede Trust’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
11,076
+103
+0.9% +$2.41K ﹤0.01% 1163
2026
Q1 		$209K Buy
10,973
+349
+3% +$7.71K ﹤0.01% 1287
2025
Q4 		$257K Buy
+10,624
New +$278K ﹤0.01% 1205
2025
Q1 		$234K Buy
10,228
+1,831
+22% +$48.2K ﹤0.01% 1169
2024
Q4 		$218K Buy
+8,397
New +$209K ﹤0.01% 1210
2022
Q4 		– Sell
-13,703
Closed -$311K – 1289
2022
Q3 		$311K Sell
13,703
-12,428
-48% -$266K ﹤0.01% 940
2022
Q2 		$360K Buy
26,131
+247
+1% +$3.62K ﹤0.01% 953
2022
Q1 		$588K Buy
25,884
+481
+2% +$12.7K ﹤0.01% 846
2021
Q4 		$946K Buy
25,403
+888
+4% +$38.1K ﹤0.01% 762
2021
Q3 		$1.04M Buy
+24,515
New +$1.18M 0.01% 693
2020
Q4 		– Sell
-38
Closed -$1K – 1337
2020
Q3 		$1K Buy
+38
New +$821 ﹤0.01% 2326

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Glenmede Trust's BLFS Position: Q2 2026 in Review

Glenmede Trust increased its BioLife Solutions (BLFS) stake by 0.94% in Q2 2026, buying an estimated $2.41K and bringing the position to 11,076 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

Glenmede Trust first reported a position in BLFS in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.04M in Q3 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Glenmede Trust held 11,076 shares of BioLife Solutions worth $313K as of Q2 2026.
  • Glenmede Trust bought 103 BioLife Solutions shares in Q2 2026, an estimated $2.41K.
  • BioLife Solutions made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1163 holding.
  • Glenmede Trust first reported a position in BioLife Solutions in Q3 2020 and has held it in 11 quarters since.
  • Glenmede Trust's BioLife Solutions position peaked at $1.04M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.